About this episode
In this solo episode, Craig Beavers breaks down new data from the CELEBRATE STEMI trial and the POLY-HF polypill study. He highlights what these findings could mean for real-world practice, from early antiplatelet strategies to improving adherence and outcomes in heart failure.
Show Notes:
Patient Perspectives on a Polypill Strategy for Heart Failure with Reduced Ejection Fraction: A Convergent-Parallel Mixed Methods Study Embedded in a Randomized Clinical Trial
Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction
